Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-106587
Filing Date
2025-08-11
Accepted
2025-08-11 16:26:07
Documents
60
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pali-20250630.htm   iXBRL 10-Q 2022115
2 EX-31.1 pali-ex31_1.htm EX-31.1 17767
3 EX-31.2 pali-ex31_2.htm EX-31.2 18013
4 EX-32.1 pali-ex32_1.htm EX-32.1 11767
  Complete submission text file 0000950170-25-106587.txt   7078739

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pali-20250630.xsd EX-101.SCH 931709
62 EXTRACTED XBRL INSTANCE DOCUMENT pali-20250630_htm.xml XML 1155181
Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

EIN.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33672 | Film No.: 251202381
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)